Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

A note on the estimation of relative risks of rare genetic susceptibility markers.

Begg CB, Berwick M.

Cancer Epidemiol Biomarkers Prev. 1997 Feb;6(2):99-103.

3.

Further development of the case-only design for assessing gene-environment interaction: evaluation of and adjustment for bias.

Gatto NM, Campbell UB, Rundle AG, Ahsan H.

Int J Epidemiol. 2004 Oct;33(5):1014-24. Epub 2004 Sep 9. Review.

PMID:
15358745
4.

Genetic Epidemiology--science and ethics on familial cancers.

Hemminki K.

Acta Oncol. 2001;40(4):439-44. Review.

PMID:
11504301
5.

A design for cancer case-control studies using only incident cases: experience with the GEM study of melanoma.

Begg CB, Hummer AJ, Mujumdar U, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Culver HA, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Busam K, From L, Berwick M; GEM Study Group..

Int J Epidemiol. 2006 Jun;35(3):756-64. Epub 2006 Mar 23.

PMID:
16556646
6.

Population stratification bias in the case-only study for gene-environment interactions.

Wang LY, Lee WC.

Am J Epidemiol. 2008 Jul 15;168(2):197-201. doi: 10.1093/aje/kwn130. Epub 2008 May 22.

PMID:
18497429
7.

[Molecular and genetic epidemiology].

Kang DH.

Exp Mol Med. 2001 Apr 21;33(1 Suppl):73-82. Korean.

8.

Genetic dissection methods: designs used for tests of gene-environment interaction.

Liu X, Fallin MD, Kao WH.

Curr Opin Genet Dev. 2004 Jun;14(3):241-5.

PMID:
15172665
9.

"Just Another Statistic"

Machtay M, Glatstein E.

Oncologist. 1998;3(3):III-IV.

PMID:
10388105
10.

Misclassification of genetic susceptibility biomarkers: implications for case-control studies and cross-population comparisons.

Rothman N, Stewart WF, Caporaso NE, Hayes RB.

Cancer Epidemiol Biomarkers Prev. 1993 Jul-Aug;2(4):299-303.

11.

Genetic and aging epidemiology. The merging of two disciplines.

Cauley JA, Dorman JS, Ganguli M.

Neurol Clin. 1996 May;14(2):467-75. Review.

PMID:
8827183
12.
13.

Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study.

Hsing AW, Chen C, Chokkalingam AP, Gao YT, Dightman DA, Nguyen HT, Deng J, Cheng J, Sesterhenn IA, Mostofi FK, Stanczyk FZ, Reichardt JK.

Cancer Epidemiol Biomarkers Prev. 2001 Oct;10(10):1077-82.

14.

The case-combined-control design was efficient in detecting gene-environment interactions.

Andrieu N, Goldstein AM.

J Clin Epidemiol. 2004 Jul;57(7):662-71.

PMID:
15358394
15.

EGF gene polymorphism and the risk of incident primary melanoma.

Amend KL, Elder JT, Tomsho LP, Bonner JD, Johnson TM, Schwartz J, Berwick M, Gruber SB.

Cancer Res. 2004 Apr 15;64(8):2668-72.

16.

Gene-environment interactions in breast cancer.

Chia KS.

Novartis Found Symp. 2008;293:143-50; discussion 150-5, 181-3. Review.

PMID:
18972750
17.

Relative risk for genetic associations: the case-parent triad as a variant of case-cohort design.

Ahsan H, Hodge SE, Heiman GA, Begg MD, Susser ES.

Int J Epidemiol. 2002 Jun;31(3):669-78.

PMID:
12055172
18.

[Researches on genetics and genetic epidemiology of common complex diseases: challenge and strategies].

Gu DF.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2006 Apr;28(2):115-8. Review. Chinese.

19.
20.

Supplemental Content

Support Center